Arylamine N-acetyltransferase-1 reveals a subpopulation of ALS patients with altered metabolic capacity
R. Minchin, C. Choudhury, S. Allen, M. K. Gill, F. Garton, R. Restuardi, N. J. Butcher, S. Ngo, F. J. Steyn
The paper identifies a subpopulation of ALS patients with altered metabolic capacity linked to NAT1 activity, showing higher metabolic indices and faster disease progression.
bioRxiv · Jun 29, 2023 · PreprintBiochemistry